Literature DB >> 9762709

Role of the cholinergic systems of the dorsal and ventral striatum of the rat brain in controlling learned movements.

N M Dubrovskaya1, I A Zhuravin.   

Abstract

Comparative studies were performed of the effects of injections of a cholinergic agonist (carbachol) and antagonist (scopolamine) into the ventral and dorsal striatum on the performance of a learned movement involving prolonged maintenance of extension of the forelimb in rats. Doses of carbachol (0.03-3.00 micrograms) into the ventral striatum were accompanied by increases in the numbers of movements with prolonged maintenance of extension with application of pressure against an obstacle, with a simultaneous decrease in the percentage of rapid nonreinforced movements (by an average of 18.8%). Injections into the dorsal striatum disrupted slow movements which were not reinforced during training, on a background of stable performance of the learned reflex. Doses of scopolamine (0.3-3.0 micrograms) into both the dorsal and ventral parts of the striatum produced increases (by 22.7 +/- 8.2% and 68.9 +/- 14.3%) in the numbers of rapid nonreinforced movements typical of the repertoire of untrained animals. These data led to the suggestion that the cholinergic system of the ventral striatum is involved in the maintenance of forelimb muscle tone in rats during the performance of movements in which pressure is applied to an obstacle. The cholinergic system of the dorsal striatum does not have this property, but plays a significant role in the process of learning new sensory-controlled movements.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9762709     DOI: 10.1007/bf02464792

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  17 in total

Review 1.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones.

Authors:  A D Smith; J P Bolam
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

Review 2.  A consideration of sensory factors involved in motor functions of the basal ganglia.

Authors:  T I Lidsky; C Manetto; J S Schneider
Journal:  Brain Res       Date:  1985-06       Impact factor: 3.252

3.  [The sensory and motor components of different forms of learned movement during a change in the activity of the neostriatal cholinergic system].

Authors:  K B Shapovalova; I A Zhuravin; E V Pominova; N M Dubrovskaia; G A Diubkacheva
Journal:  Fiziol Zh Im I M Sechenova       Date:  1994-12

4.  Role of the striatal cholinergic system in the regulation of learned manipulation in rats.

Authors:  N M Dubrovskaya; I A Zhuravin
Journal:  Integr Physiol Behav Sci       Date:  1995 Apr-Jun

5.  GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: differences between dorsal and ventral striatum.

Authors:  L Turski; U Havemann; K Kuschinsky
Journal:  Brain Res       Date:  1984-11-19       Impact factor: 3.252

Review 6.  [The role of subcortical structures in the conditioning process].

Authors:  N F Suvorov
Journal:  Fiziol Zh Im I M Sechenova       Date:  1995-11

7.  Differential effects of striatal injections of dopaminergic, cholinergic and GABAergic drugs upon swimming behavior of rats.

Authors:  M C Vrijmoed-de Vries; A R Cools
Journal:  Brain Res       Date:  1986-01-29       Impact factor: 3.252

8.  Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.

Authors:  M Xu; F Mizobe; T Yamamoto; T Kato
Journal:  Brain Res       Date:  1989-08-28       Impact factor: 3.252

9.  The nucleus accumbens and forelimb muscular rigidity in rats.

Authors:  B A Ellenbroek; J Van den Hoven; A R Cools
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

10.  [The effect of exogenous gangliosides on the formation in rats of instrumental movements with tactile control].

Authors:  I A Zhuravin; N N Nalivaeva; N M Dubrovskaia
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1993 Nov-Dec       Impact factor: 0.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.